MedPath
HSA Approval

DBL ACICLOVIR INTRAVENOUS INFUSION 250mg/10ml

SIN09367P

DBL ACICLOVIR INTRAVENOUS INFUSION 250mg/10ml

DBL ACICLOVIR INTRAVENOUS INFUSION 250mg/10ml

June 13, 1997

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

J05AB01

aciclovir

Manufacturer Information

PFIZER PRIVATE LIMITED

HOSPIRA AUSTRALIA PTY LTD

Active Ingredients

ACICLOVIR

250mg

Acyclovir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.